These previous studies have analyzed T –cell immunity to COVID-19 mRNA vaccination in patients with hematological malignancies by intracellular cytokine staining and flow cytometry, or by measurement of secreted IFN-γ/IL-2 by ELISpot or FluoroSpot techniques. The gene discussed is IL2; the disease is hematologic disorder.